Physician profile
Erin Lowe
NPI 1528416633
$9,474.76
in general payments reported to CMS, 2019-2025
35 companies · $1,665 in 2025
The $1,665 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $974 · 2020: $489 · 2021: $1,565 · 2022: $1,392 · 2023: $1,540 · 2024: $1,850 · 2025: $1,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,841 · Education: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,840.52 |
| Education | $214.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,782.81 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $803.65 | 2019-2025 | Ilumya, Blu-U, Odomzo |
| Pfizer INC. | $758.84 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $590.82 | 2020-2024 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $450.76 | 2021-2024 | |
| Lilly USA, LLC | $415.26 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $376.64 | 2020-2024 | Otezla |
| Leo Pharma INC. | $365.66 | 2020-2025 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $348.50 | 2019-2025 | Cabtreo, Jublia, Siliq |
| Incyte Corporation | $344.69 | 2021-2025 | Opzelura |
| Galderma Laboratories, L.P. | $305.43 | 2021-2025 | Nemluvio, Aklief, Dysport |
| Genzyme Corporation | $301.36 | 2019-2025 | |
| Ucb, INC. | $272.20 | 2021-2025 | Bimzelx, Cimzia |
| Genentech USA, INC. | $115.65 | 2019 | |
| Arcutis Biotherapeutics, INC. | $114.45 | 2023-2024 | Zoryve |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $106.80 | 2021-2023 | Tremfya |
| Cardinal Health 414 LLC | $95.92 | 2019 | |
| Merz North America, INC. | $87.37 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $85.70 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $81.01 | 2023-2024 | Sotyktu |
| Dermavant Sciences, INC. | $79.49 | 2023-2024 | Vtama |
| Biofrontera INC. | $77.33 | 2019-2021 | |
| Hydrofera LLC | $75.57 | 2024-2025 | Hydrofera Blue |
| Organon LLC | $67.94 | 2025 | Vtama |
| Almirall LLC | $67.04 | 2021-2023 | Seysara |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.90 | 2022-2023 | Spevigo |
| Dermira, INC. | $41.16 | 2020-2021 | |
| Genentech, INC. | $39.95 | 2019 | |
| Botanix Sb INC | $37.90 | 2025 | Sofdra |
| Organogenesis INC. | $29.41 | 2022 | |
| Vyne Pharmaceuticals INC. | $26.54 | 2021 | |
| Dusa Pharmaceuticals, INC. | $24.57 | 2019 | |
| Allergan, INC. | $24.29 | 2021 | |
| Journey Medical Corporation | $22.20 | 2025 | |
| Mayne Pharma Commercial LLC | $15.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.